Rimantadine
Flumadine (rimantadine) is a small molecule pharmaceutical. Rimantadine was first approved as Flumadine on 1993-09-17. It is used to treat human influenza in the USA.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
Flumadine (generic drugs available since 2002-08-30)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Rimantadine hydrochloride
Tradename | Company | Number | Date | Products |
|---|---|---|---|---|
| FLUMADINE | Sun Pharmaceutical Industries | N-019649 RX | 1993-09-17 | 1 products, RLD, RS |
Show 1 discontinued
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| rimantadine hydrochloride | ANDA | 2019-05-27 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| human influenza | EFO_0007328 | D007251 | J11.1 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Clinical Trials
22 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | 1 | 1 | 1 | 3 |
| Torticollis | D014103 | HP_0000473 | F45.8 | — | 2 | — | 1 | — | 3 |
| Neoplasms | D009369 | C80 | — | — | — | 1 | — | 1 | |
| Wounds and injuries | D014947 | T14.8 | — | — | — | 1 | — | 1 | |
| Spinal cord injuries | D013119 | EFO_1001919 | — | — | — | 1 | — | 1 | |
| Brain injuries | D001930 | S06.9 | — | — | — | 1 | — | 1 | |
| Dystonic disorders | D020821 | G24 | — | — | — | 1 | — | 1 | |
| Low back pain | D017116 | HP_0003419 | M54.5 | — | — | — | 1 | — | 1 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sialorrhea | D012798 | HP_0002307 | K11.7 | — | 2 | 4 | — | — | 5 |
| Cerebral palsy | D002547 | G80 | 1 | 2 | 1 | — | — | 2 | |
| Multiple sclerosis | D009103 | EFO_0003885 | G35 | — | 1 | 1 | — | — | 1 |
| Traumatic brain injuries | D000070642 | S06 | — | 1 | 1 | — | — | 1 | |
| Amyotrophic lateral sclerosis | D000690 | EFO_0000253 | G12.21 | — | 1 | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Systemic scleroderma | D012595 | EFO_0000717 | M34 | — | 1 | — | — | — | 1 |
| Hyperhidrosis | D006945 | HP_0000975 | — | 1 | — | — | — | 1 | |
| Abdominal hernia | D046449 | K46 | — | 1 | — | — | — | 1 | |
| Ventral hernia | D006555 | EFO_1001866 | K43 | — | 1 | — | — | — | 1 |
Indications Phases 1
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | RIMANTADINE |
| INN | rimantadine |
| Description | 1-(1-adamantyl)ethanamine is an alkylamine. |
| Classification | Small molecule |
| Drug class | antivirals/antiparkinsonians (adamantane derivatives) |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(N)C12CC3CC(CC(C3)C1)C2 |
Identifiers
| PDB | — |
| CAS-ID | 13392-28-4 |
| RxCUI | 9386 |
| ChEMBL ID | CHEMBL959 |
| ChEBI ID | — |
| PubChem CID | 5071 |
| DrugBank | DB00478 |
| UNII ID | 0T2EF4JQTU (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 2,807 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
208 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more